Winton Group LTD I Bio, Inc. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$1.06 - $1.52 $82,369 - $118,114	-77,707 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$1.22 - $1.65 $31,899 - $43,142	-26,147 Reduced 25.18%	77,707 $117,000
Q1 2021 Jul 21, 2021	BUY	$1.18 - $2.62 $102,702 - $228,034	87,036 Added 517.52%	103,854 $160,000
Q4 2020 Feb 12, 2021	SELL	$1.05 - $2.24 $14,815 - $31,606	-14,110 Reduced 45.62%	16,818 $18,000
Q3 2020 Oct 30, 2020	BUY	$1.7 - $6.41 $14,376 - $54,209	8,457 Added 37.64%	30,928 $63,000
Q2 2020 Aug 05, 2020	BUY	$0.87 - $2.46 $19,549 - $55,278	22,471 New	22,471 $50,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.7M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.